CASI Pharmaceuticals (NASDAQ: CASI) reported Q1 EPS of ($0.06), versus ($0.05) reported last year. Revenue for the quarter came in at $23.7 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharmaceuticals (CASI) click here.